Clinical Study
Expression and Clinical Significance of Antiapoptotic Gene (Survivin) in NB4 and Acute Promyelocytic Leukemia Cells
Table 1
The results of survivin mRNA expression in de novo, relapse, and remission APL.
| Group | | survivin-mRNA expression | positive | value |
| (1) de novo and relapse* | 36 | 24 (67%) | | L type (+)# | 28 | 19 (68%) | | S type (+) | 8 | 5 (63%) | | (2) remission& | 22 | 8 (36%) | | (3) acute leukemia | 23 | 21 (91%) | |
|
|
Compared by remission , ; ; compared by acute leukemia ; .
|